Researchers
Drulović, Jelena
Results 61-80 of 386
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD![]() | Cacciaguerra, Laura; Pagani, Elisabetta; Radaelli, Marta; Mesaroš, Šarlota T. | Article | 21a+M21a+ |
| 2022 | Phenotypic and Genetic Heterogeneity of Adult Patients with Hereditary Spastic Paraplegia from Serbia![]() | Perić, Stojan | Article | 21M21 |
| 2022 | Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders![]() | Habek, Mario; Andabaka, Marko M. | Article | 21aM21a |
| 2022 | COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders![]() | Jovićević, Vanja; Ivanović, Jovana B.; Andabaka, Marko M. | Article | 21M21 |
| 2022 | COVID-19 associated myelitis: early insights from a multi-center study![]() | Adamec, Ivan; Brecl Jakob, Gregor; Drulović, Jelena S.
Jerse, Jana; Gomezelj, Sarah; Krbot-Škorić, Magdalena; Habek, Mario;
| Conference Paper | Mp. category will be shown later |
| 2022 | Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Large Cohort of Relapsing-Remitting MS Patients![]() | Drulović, Jelena | Article | 22M22 |
| 2022 | Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data![]() | Marić, Gorica D. | Article | 22M22 |
| 2022 | Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders![]() | Habek, Mario; Andabaka, Marko M. | Conference Paper | Mp. category will be shown later |
| 2022 | MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis![]() | De Vito, Francesca; ...; Drulović, Jelena S. | Article | 21aM21a |
| 2022 | Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity![]() | Gilio, Luana; ...; Pekmezović, Tatjana D. | Article | 21aM21a |
| 2022 | Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders![]() | Tabansky, Inna; ...; Dujmović, Irena | Article | 21aM21a |
| 2022 | Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w-ratio: a multicenter study![]() | Margoni, Monica; ...; Mesaroš, Šarlota T. | Conference Paper | Mp. category will be shown later |
| 2022 | Unilateral Left Frontal Lobe Lesion in a Marburg's Variant of Multiple Sclerosis Patient with Impaired Swallowing and Speech: A 3-Year Clinical/Brain MRI Follow-up![]() | Ivanović, Jovana B. | Article | 22M22 |
| 2022 | Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study![]() | Wray, Sibyl; ...; Drulović, Jelena S. | Article | 21M21 |
| 2022 | Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study![]() | Margoni, Monica; ...; Mesaroš, Šarlota T. | Article | 21a+M21a+ |
| 2022 | Transverse myelitis following COVID-19: Insights from a multi-center study and systematic literature review![]() | Adamec, Ivan; ...; Drulović, Jelena S.
(broj koautora 16);
| Article | 21M21 |
| 2022 | Impact of comorbidities on the disability progression in multiple sclerosis![]() | Marić, Gorica D. | Article | 21M21 |
| 2021 | Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis![]() | Stampanoni-Bassi, Mario; ...; Pekmezović, Tatjana D. | Article | 21M21 |
| 2021 | Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations![]() | Cacciaguerra, Laura; Storelli, Loredana; Radaelli, Marta; Mesaroš, Šarlota T. | Conference Paper | Mp. category will be shown later |
| 2021 | Comparison of the 2017 and 2010 Revisions of the McDonald Criteria in Patients with CIS Suggestive of MS: A Multicentre MAGNIMS Study![]() | Filippi, Massimo; ...; Mesaroš, Šarlota T. | Conference Paper | Mp. category will be shown later |
